Goodwin Procter Advised SixPeaks Bio on Acquisition by AstraZeneca for Up to $300 MillionThe Global Law firm, Goodwin's Life Sciences team advised SixPeaks Bio in its acquisition by AstraZeneca for a...
Goodwin advised Harbour BioMed on $175 million global strategic collaboration with AstraZenecaGoodwin Procter LLP advised Harbour BioMed on a strategic global collaboration agreement with AstraZeneca...
Covington Advised AstraZeneca On Acquisition Of EsoBiotec Covington advised AstraZeneca on its definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies...
Covington & Burling And Cooley Guide AstraZeneca And EsoBiotec On Acquisition Of Cancer Treatment Company The deal includes an initial payment of $425m at closing and up to $575m later ...
Cooley Advised EsoBiotec On Its $1 Billion Acquisition By AstraZeneca An initial payment of $425 million will be made at closing and up to $575 million in contingent consideration based on...
Pfizer Emerges Victorious, Secures $107.5 Million from AstraZeneca in US Cancer Drug Patent Trial AstraZeneca has been ordered to pay $107.5 million in damages to Pfizer. The jury found that...
AstraZeneca Admits Rare Side Effects Of Covid-19 Vaccine Amid Legal Battle In a recent legal development, AstraZeneca has admitted that its Covid-19 vaccine, sold under brand names like Covishield...
U.S. Federal Court Approves Bristol Myers Squibb & AstraZeneca Joint Stipulations to Dismiss Patent Infringement Lawsuits The U.S. Federal Court in Delaware by its presiding Judge Matthew F....
Delhi High Court Dismissed Westcoast’s Plea: No Bar on Institution of Patent Infringement Suit in Pendency of Post-Grant Opposition The Delhi High Court while rejecting the Westcoast Pharmaceutical’s...
Delhi High Court dismisses AstraZeneca plea saying two patents cannot be granted for one invention Two patents cannot be granted for one invention – one for genus and the other for species, the...
AstraZeneca gets relief from the Court for its drug Symbicort The case was based on the contention that the patent was not valid in the US for being obvious. The court ruled in favour of AstraZeneca...
Alexa-Zeneca buys US biotech company Alexion for $39 billion advised by Freshfields, Wachtell and Macfarlanes While awaiting approval to roll out Covid-19 vaccine, the deal will make the British...
